Dear Business & Industry Insider,
One of the more intriguing success stories in medical imaging in recent years is that of OsiriX, an open-source software application for viewing and manipulating medical images. A growing number of imaging specialists have downloaded the software for free, and are putting it through its paces in both clinical and research environments.
But OsiriX's growing popularity also raises some intriguing questions regarding open-source software. Can radiologists use OsiriX for primary diagnosis if they have a version of the software that hasn't received regulatory clearance? Who decides what updates and enhancements go into future "official" releases? And should there be a centralized location for OsiriX training and development?
We try to answer a few of these questions with this edition's Insider Exclusive, in which we discuss OsiriX's future with Dr. Osman Ratib, one of the original developers of the software. Dr. Ratib describes the philosophy behind OsiriX, why it's based on open-source code, and where it's going in the future. Learn more by clicking here.
In other recent news in the community, check out our article on the emergence this week of Lantheus Medical Imaging as the new incarnation of the business formerly known as Bristol-Myers Squibb Medical Imaging. Lantheus faces challenges ahead as its lead product, Cardiolite, loses patent protection this summer. Get the rest of the story by clicking here.
Also, check out our story on a major change in litigation proceedings against MRI contrast developers filed by patients who have developed nephrogenic systemic fibrosis (NSF). All cases filed in U.S. federal courts have been centralized in a single federal court in Ohio for the pretrial discovery phase. Find out how this could affect the cases by clicking here.
If you have an idea for a story you'd like to see covered in the community, feel free to drop me a line at [email protected].
